These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 30823868)
1. Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. Nichols R; Skljarevski V; Dell'Agnello G; Hundemer HP; Aurora SK J Headache Pain; 2019 Mar; 20(1):22. PubMed ID: 30823868 [No Abstract] [Full Text] [Related]
2. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. Sacco S; Bendtsen L; Ashina M; Reuter U; Terwindt G; Mitsikostas DD; Martelletti P J Headache Pain; 2019 Jan; 20(1):6. PubMed ID: 30651064 [TBL] [Abstract][Full Text] [Related]
3. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018. Tepper SJ Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405 [TBL] [Abstract][Full Text] [Related]
4. Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents. Szperka CL; VanderPluym J; Orr SL; Oakley CB; Qubty W; Patniyot I; Lagman-Bartolome AM; Morris C; Gautreaux J; Victorio MC; Hagler S; Narula S; Candee MS; Cleves-Bayon C; Rao R; Fryer RH; Bicknese AR; Yonker M; Hershey AD; Powers SW; Goadsby PJ; Gelfand AA Headache; 2018 Nov; 58(10):1658-1669. PubMed ID: 30324723 [No Abstract] [Full Text] [Related]
5. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment. Tepper SJ Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830 [TBL] [Abstract][Full Text] [Related]
9. The CGRP Pathway in Migraine as a Viable Target for Therapies. Edvinsson L Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153 [TBL] [Abstract][Full Text] [Related]
10. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine. Maasumi K; Michael RL; Rapoport AM Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205 [TBL] [Abstract][Full Text] [Related]
11. How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice. Tiseo C; Ornello R; Pistoia F; Sacco S J Headache Pain; 2019 May; 20(1):49. PubMed ID: 31060490 [TBL] [Abstract][Full Text] [Related]
12. Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention. Mikol DD; Snellman J J Headache Pain; 2019 Jun; 20(1):67. PubMed ID: 31164079 [No Abstract] [Full Text] [Related]
13. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data. Khan S; Olesen A; Ashina M Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503 [TBL] [Abstract][Full Text] [Related]
14. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications. Dodick DW Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365 [TBL] [Abstract][Full Text] [Related]
15. A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine. Reuter U Headache; 2018 May; 58 Suppl 1():48-59. PubMed ID: 29697156 [TBL] [Abstract][Full Text] [Related]
16. Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents. Greene KA; Gentile CP; Szperka CL; Yonker M; Gelfand AA; Grimes B; Irwin SL Pediatr Neurol; 2021 Jan; 114():62-67. PubMed ID: 33232919 [TBL] [Abstract][Full Text] [Related]